Metabolic control of type-2 diabetic patients commonly treated with sulphonylureas in a developing country

East African Medical Journal

Volumn 80, Issue 4, 2003, Pages 175-180

  Ezenwaka, C E ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AFRICA; AGED; ARTICLE; DEVELOPING COUNTRY; ETHNOLOGY; FEMALE; HUMAN; INDIA; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; TRINIDAD AND TOBAGO;

ADULT; AFRICA; AGED; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; MALE; MIDDLE AGED; SULFONYLUREA COMPOUNDS; TRINIDAD AND TOBAGO;

EID: 0041883604     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Barnett, A.H., Effo, C., Leslie, R.D. and Pyke, D.A. Diabetes in identical twins: a study of 200 pairs. Diabetologia. 1981; 20:87-93.
2. Newman, B., Selby, J.V., King, MC, Slemenda, C., Fabsitz, R. and Friedman, G.D. Concordance for type 2 (NIDDM) diabetes in male twins. Diabetologia. 1987; 30:763-768.
3. Weir, G.C. Non-insulin dependent diabetes mellitus: interplay between B-Cell inadequacy and insulin resistance. Am. J. Med. 1982; 73:461-464.
4. Olefsky, J.M., Kolterman, O.G. and Scarlett., J.A. Insulin action and resistance in obesity and NIDDM. Am. J. Physiol. 1982; 243:E15-E30.
5. DeFronzo, R.A., Simmonson, D. and Ferrannini, E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin dependent) and type 1 (insulin dependent) diabetes mellitus. Diabetologia. 1982; 23:313-319.
6. Reaven, G.M. Role of insulin resistance in human disease. Diabetes. 1988; 37:1595-1607.
7. DeFronzo, R.A. and Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic vascular disease. Diabetes Care. 1991; 18:173-194.
8. United Kingdom Prospective Diabetes Study (UKPDS)Group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with Type 1 diabetes (UKPDS 33). Lancet. 1998; 352:837-853.
9. Efendic, S. GLP-1 as a therapeutic approach in Type 2 diabetes. Diabetes Rev Int. 1998; 7:2-5.
10. Florkowski, C.M. Outcomes of Type 2 diabetes. Diabetes Rev. Int. 1998; 7:6-8.
11. The Expert Panel. Report of the National Cholesterol Education Programme. Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch. Intern. Med. 1988; 148:36-69.
12. Castelli, W.P., Abbot, R.D. and McNamara, P.M. Summary estimates of cholesterol used to predict coronary heart disease. Circulation. 1983; 67:730-734.
13. World Health Organization Working Group. Use and interpretation of anthropometric indicators of nutritional status. WHO Bulletin. 1986; 64:929-941.
14. Friedwald, W.T., Levy, R.I. and Fredrickson, D.S. Estimation of the concentration of low- density lipoprotein in plasma without use of preparative ultracentrifuge. Clin. Chem. 1972; 18:499-502.
15. Matthews, D.R., Hosker J.P., Rudenski, A.S., Naylor, B.A., Treacher D.F. and Tumer, R.C. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in mail. Diabetologia. 1985; 28:412-419.
16. SPSS for Windows. User's Guide, New York: McGraw-Hill. 1999.
17. Gurney, M. and Gorstein, J. The global prevalence of obesity - an initial overview of available data. World Hlth. Statis Q. 1988; 41:251-254.
18. Ezenwaka, E.C., Akanji, A.O., Akanji, B.O., Unwin, N.C. and Adejuwon, C.A. The Prevalence of insulin resistance and other cardiovascular disease risk factors in healthy elderly Southwestern Nigerians. Atherosclerosis. 1997; 128:201-211.
19. Ezenwaka, E.C. and Davis, G. Increased cardiovascular risk factors in newly diagnosed type 2 diabetic patients in a primary health care center in Trinidad. Diabetes Res. Clin. Pract. 2000; 50:137-145.
20. Tuomilehto, J., Lindstrom, J., Eriksson, J.G. et al. Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001; 344:1343-1350.
21. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Diet and exercise dramatically delay type 2 diabetes, diabetes medication metformin also effective. NIDDK Fact Sheet Monday. August 2001; 6.
22. Bonora, E. and Muggeo, M. Post-prandial blood glucose as a risk factor for cardiovascular disease in type 11 diabetes: the epidemiological evidence. Diabetologia. 2001; 44:2107-2114.
23. Stratton, I.M., Adler, A.I., Neil, H.A. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Brit. Med. J. 2000; 321:405-412.
24. Ezenwaka, C.E. and Offiah, N.V. Classical cardiovascular risk factors in Trinidadian patients with Type 2 diabetes mellitus are not influenced by the level of plasma glycaemia. West Indian Med. J. 2001; 50:288-292.
25. DeFronzo, R.A. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes. 1979; 28:1095-1101.
26. Haffner, S.M., Mykkanen, L., Stern, M.P., Paidi, M. and Howard, B.V. Greater effect of diabetes on LDL size in women than in men. Diabetes Care. 1994; 17:1164-1171.
27. Miller, G.J., Beekles, G.L., Maude, G.H. et al. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey. Trinidad. Int. J. Epidemiol. 1989; 18:808-817.
28. Ezenwaka, C. and Offiah, N.V. Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies. Clin. Exp. Med. 2001; 1:91-98.
29. Targher, G., Alberiche M., Zenere, M.B., Bonadonna, R.C. Muggeo, M. and Bonora, E. Cigarette smoking and insulin resistance in patients with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol Metab. 1997; 82:3619-3624.
30. The QuED Study Group: The relationship between physician' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. Diabetes Care. 2001; 24:423-429.
31. Bonora, E., Targher, G., Alberiche, M. et al. Homeostasis Model Assessment closely mirrors the glucose Clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23:57-63.